Cargando…
The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
BACKGROUND: In proliferative diabetic retinopathy (PDR), vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) cause blindness by neovascularization and subsequent fibrosis, but their relative contribution to both processes is unknown. We hypothesize that the balance b...
Autores principales: | Kuiper, Esther J., Van Nieuwenhoven, Frans A., de Smet, Marc D., van Meurs, Jan C., Tanck, Michael W., Oliver, Noelynn, Klaassen, Ingeborg, Van Noorden, Cornelis J. F., Goldschmeding, Roel, Schlingemann, Reinier O. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2443281/ https://www.ncbi.nlm.nih.gov/pubmed/18628999 http://dx.doi.org/10.1371/journal.pone.0002675 |
Ejemplares similares
-
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
por: Van Geest, Rob J, et al.
Publicado: (2012) -
Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment
por: Klaassen, Ingeborg, et al.
Publicado: (2022) -
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease
por: Wang, Qingjian, et al.
Publicado: (2011) -
Endothelial Tip Cells in Ocular Angiogenesis: Potential Target for Anti-Angiogenesis Therapy
por: Siemerink, Martin J., et al.
Publicado: (2013) -
The role of plasmalemma vesicle-associated protein in pathological breakdown of blood–brain and blood–retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema
por: Bosma, Esmeralda K., et al.
Publicado: (2018)